SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-120871
Filing Date
2019-04-26
Accepted
2019-04-26 07:26:02
Documents
7
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d677210ddefa14a.htm DEFA14A 33734
2 GRAPHIC g677210g04m63.jpg GRAPHIC 8276
3 GRAPHIC g677210g29i76.jpg GRAPHIC 8402
4 GRAPHIC g677210g33s73.jpg GRAPHIC 8474
5 GRAPHIC g677210g34u09.jpg GRAPHIC 8367
6 GRAPHIC g677210g50y70.jpg GRAPHIC 9176
7 GRAPHIC g677210g78z13.jpg GRAPHIC 9231
  Complete submission text file 0001193125-19-120871.txt   74827
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38537 | Film No.: 19769359
SIC: 2836 Biological Products, (No Diagnostic Substances)